|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.335 CAD | 0.00% |
|
-25.56% | +52.27% |
| Apr. 19 | Biosenta Inc. announced that it expects to receive CAD 0.6 million in funding | CI |
| Mar. 27 | Biosenta Inc. Announces Successful Launch of Bench Scale Production Plant | CI |
Biosenta Inc. reported earnings results for the full year ended September 30, 2022. For the full year, the company reported sales was CAD 0.001151 million compared to CAD 0.151497 million a year ago. Revenue was CAD 0.001151 million compared to CAD 0.168105 million a year ago.
Net loss was CAD 1.46 million compared to CAD 2.04 million a year ago. Basic loss per share from continuing operations was CAD 0.07 compared to CAD 0.11 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +52.27% | 7.25M | |
| +12.44% | 25.93B | |
| +2.73% | 18.18B | |
| -26.63% | 6.09B | |
| +6.04% | 5.98B | |
| -5.67% | 3.06B | |
| +5.20% | 2.42B | |
| -12.14% | 1.85B | |
| +27.19% | 936M | |
| -4.16% | 618M |
BIOSENTA INC. 
